Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017 BIOTRONIK Release: New ICD Lead With Helical Design Now Launched In Europe April 5, 2017 Maryland's Precision Medicine Group Lands $275M December 26, 2017
Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017
